AEVI-001

null · Aevi Genomic Medicine, LLC, a Cerecor company

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AEVI-001, covering 2019-07-16 to 2019-07-16. Get the full timeline:

Most recent: Clinical Trial Update: PART B: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and Without mGluR Mutations [Phase 2]

See pricing